Trial Profile
Efficacy and safety of AVT-01 10 mg once daily over 7 days in patients with moderate persistent atopic asthma A double-blind, randomized, placebo-controlled clinical study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Aug 2017
Price :
$35
*
At a glance
- Drugs AVT 01 (Primary)
- Indications Allergic asthma
- Focus Therapeutic Use
- Sponsors DOLTHERA
- 01 Aug 2017 New trial record